JGASX
Price
$44.90
Change
-$0.01 (-0.02%)
Updated
Sep 5 closing price
Net Assets
22.92B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

JGASX vs RGEBX

Header iconJGASX vs RGEBX Comparison
Open Charts JGASX vs RGEBXBanner chart's image
JPMorgan Growth Advantage I
Price$44.90
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets22.92B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
JGASX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JGASX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGASX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. JGASX (22.9B). JGASX (0.00) and RGEBX (0.00) have matching dividends . JGASX was incepted earlier than RGEBX: JGASX (19 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than JGASX (0.83). JGASX is a more actively managed with annual turnover of: 28.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than JGASX: RGEBX (250) vs JGASX (1000000). JGASX (17.97) and RGEBX (17.59) have marching annual gain over last year. JGASX return over 5 years is better than : 49.50 vs. RGEBX (38.71).
JGASXRGEBXJGASX / RGEBX
Total Expense Ratio0.741.0968%
Annual Report Gross Expense Ratio0.831.0976%
Fund Existence19 years11 years-
Gain YTD11.41415.39874%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.9B332B7%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.9717.59102%
Returns for 3 years79.6057.61138%
Returns for 5 years49.5038.71128%
Returns for 10 years185.8091.44203%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In